Strikingly, low EGR1 levels were significantly associated with poor tumor histology (well: 68.4% (13/19); moderate: 55.6% (5/9); poor: 90.0% (27/30)) (P = 0.040), but not with age, gender, or TNM stage. Here, EGR1 is linked to neoplasm.